815
Views
42
CrossRef citations to date
0
Altmetric
Original Articles: Research

Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells

, , , , , , , , , , , & show all
Pages 1544-1555 | Received 08 Feb 2011, Accepted 27 Feb 2011, Published online: 23 Jun 2011

References

  • The Leukemia & Lymphoma Society. Facts 2010–2011 [Internet]. 2010. Available from: http://www.lls.org/resourcecenter/freeeducationmaterials/generalcancer/facts
  • American Cancer Society. Cancer Facts & Figures 2010. AtlantaACS2010.
  • Reichmann R. Acute lymphoblastic leukaemia: a review. Trinity Stud Med J 2000;1:26–28.
  • Aldana-Masangkay GI, Sakamoto KM. HDAC6 and its role in cancer. J Biomed Biotech 2011;2011:875824.
  • Matsuyama A, Shimazu T, Sumida Y, et al. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J 2002;21:6820–6831.
  • Valenzuela-Fernandez A, Roman-Cabrero J, Serrador JM, Sanchez-Madrid F. HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol 2008;18:291–297.
  • Cabrero JR, Serrador JM, Barreiro O, et al. Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity. Mol Biol Cell 2006;17:3435–3445.
  • Arce CA, Casale CH, Barra HS. Submembraneous microtubule cytoskeleton: regulation of ATPases by interaction with actetylated tubulin. FEBS J 2008;275:4664–4674.
  • Hideshima T, Bradner JE, Wong J, et al. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. Proc Natl Acad Sci USA 2005;102:8567–8572.
  • Rodriguez-Gonzalez A, Lin T, Ikeda AK, Simms-Waldrip T, Fu C, Sakamoto KM. Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation. Cancer Res 2008;68:2557–2560.
  • Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci USA 2003;100:4389–4394.
  • Haggarty SJ, Koeller KM, Wong JC, Butcher RA, Schreiber SL. Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-base assays. Chem Biol 2003;10:383–396.
  • Boulares AH, Yakovlev AG, Ivanova V, et al. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. J. Biol Chem 1999;274:22932–22940.
  • Casale CH, Previtali G, Barra HS. Involvemet of acetylatied tubulin in the regulation of Na+,K+-ATPase activity in cultured astrocytes. FEBS J 2003;534:115–118.
  • James PF, Grupp IL, Grupp G, et al. Identification of a specific role for the Na,K-ATPase alpha 2 isoform as a regulator of calcium in the heart. Mol Cell 1999;3:555–563.
  • Grupp I, Im WB, Lee CO, Lee SW, Pecker MS, Schwartz A. Relation of sodium pump inhibition to positive inotropy at low concentrations of ouabain in rat heart muscle. J Physiol 1985;360:149–160.
  • Rakowski RF, Gadsby DC, de Weer P. Stoichiometry and voltage dependence of the sodium pump in voltage-clamped, internally dialyzed squid giant axon. J Gen Physiol 1989;93:903–941.
  • Lingrel JB, Kuntzweiler T. Na+,K+-ATPase. J Biol Chem 1994;269:19659–19662.
  • Koksoy AA. Na+,K+-ATPase: a review. J Ankara Med Sch 2002;24:73–82.
  • Fujiki Y, Hubbard AL, Fowler S, Lazarow PB. Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J Cell Biol 1982;93:97–102.
  • Alonso A del C, Nunez-Fernandez M, Beltramo DM, Casale CH, Barra HS. Na+,K+-ATPase was found to be the membrane component responsible for the hydrophobic behaviour of the brain membrane tubulin. Biochem Biophys Res Commun 1998;253:924–927.
  • Santander VS, Bising CG, Purro SA, Casale CH, Arce CA, Barra HS. Tubulin must be acetylated in order to form a complex with membrane Na+,K+-ATPase and to inhibit its enzyme activity. Mol Cell Biochem 2006;291:167–174.
  • Nobel CS, Aronson JK, van den Dobbelsteen DJ, Slater AFG. Inhibition of Na+-K+-ATPase may be one mechanism contributing to potassium efflux and cell shrinkage in CD95-induced apoptosis. Apoptosis 2000;5:153–163.
  • Esmann M. ATPase and phosphatase activity of Na+,K+-ATPase: molar and specific activity, protein determination. Meth Enzymol 1979;156:105–115.
  • Trageser D, Iacobucci I, Nahar R, et al. Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. J Exp Med 2009;206:1739–1753.
  • Klemm L, Duy C, Iacobucci I, et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell 2009;16:232–245.
  • Dai Y, Rahmani M, Grant S. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavoripidol through a SAPK/JNK and NF-kappaβ-dependent process. Oncogene 2003;22:7108–7122.
  • Tang G, Xu Z, Golman JE. Synergistic effects of the SAPK/JNK and the proteasome pathway on glial fibrillary acidic protein (GFAP) accumulation in Alexander disease. J Biol Chem 2003;281:38634–38643.
  • Yu X, Hong S, Faustman EM. Cadmium-induced activation of stress signaling pathways, disruption of ubiquitin dependent protein degradation and apoptosis in primary rat Sertoli cell-gonocyte cocultures. Toxicol Sci 2008;104:385–396.
  • Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000;103:239–252.
  • Rao R, Fiskus W, Yang Y, et al. HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function human leukemia cells. Blood 2008;112:1886–1893.
  • Kulikov A, Eva A, Kirck U, Boldyrev A, Scheiner-Bobis G. Ouabain activates signaling pathways associated with cell death in human neuroblastoma. Biochim Biophys Acta 2007;1768:1691–1702.
  • Boyault C, Sadoul K, Pabion M, Khochbin S. HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination. Oncogene 2007;26:5468–5476.
  • Wang XQ, Xiao AY, Sheline C, et al. Apoptotic insults impair Na+,K+-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress. J Cell Biol 2003;116:2099–2110.
  • Namdar M, Perez G, Ngo L, Marks PA. Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents. Proc Natl Acad Sci USA 2001;107:20003–20008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.